Want to see JP:4023 full AI Analyst Report?
Kureha (4023) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ast-120 | Chronic Kidney Disease | Phase III | Completed | A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1) | Jul 11, 2007 | ― |
| Ast-120 | Chronic Kidney Disease | Phase III | Completed | A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2) | Jul 11, 2007 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ast-120 | Phase III | Chronic Kidney Disease | Completed | A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1) | Jul 11, 2007 | ― |
| Ast-120 | Phase III | Chronic Kidney Disease | Completed | A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2) | Jul 11, 2007 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Kureha Corporation (JP:4023) have in its pipeline
Kureha JP:4023 is currently developing the following drugs: Ast-120. These drug candidates are in various stages of clinical development as the company works toward FDA approval.